[Myoclonus in patients treated with etanercept].
Servicio de Farmacia. Hospital de la Vega Lorenzo Guirao. Cieza. Murcia. vanedole80@hotmail.com.
V
V
Domínguez Leñero
I
I
Sánchez-Martínez
M E
ME
Giménez-Cortés
F
F
Valiente-Borrego
D000293:Adolescent; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009207:Myoclonus / Q000139:chemically induced*; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept